- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT00764101
Attentional Bias Modification in Patients With Posttraumatic Stress Disorder
July 7, 2011 updated by: PsyQ
Effects of Attentional Bias Modification on Attentional Bias and Symptoms of Posttraumatic Stress Disorder
Randomized, placebo-controlled trial of 9 sessions of computerized attentional bias training on attentional bias and on symptoms of Posttraumatic Stress Disorder.
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Study Type
Interventional
Enrollment (Anticipated)
80
Phase
- Phase 2
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Zuid Holland
-
Den Haag, Zuid Holland, Netherlands, 2593 HR
- PsyQ Haaglanden, department of psychotrauma
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years and older (Adult, Older Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Description
Inclusion Criteria:
- Diagnosis of Posttraumatic Stress Disorder
Exclusion Criteria:
- Diagnosis of psychosis, drug- or alcohol dependency/abuse;
- Unable to fill in questionnaires in Dutch;
- Color blindness (Stroop test).
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Quadruple
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: 1
9 sessions of attentional bias modification (computerized training program)
|
computerized training to reduce attentional bias in posttraumatic stress disorder
Other Names:
|
|
Placebo Comparator: 2
Attentional control condition (placebo training program)
|
computerized training to reduce attentional bias in posttraumatic stress disorder
Other Names:
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Time Frame |
|---|---|
|
Clinician-Administered PTSD Scale (CAPS)
Time Frame: End of Trial + 3 week Follow-Up
|
End of Trial + 3 week Follow-Up
|
Secondary Outcome Measures
Outcome Measure |
Time Frame |
|---|---|
|
PTSD symptoms (self-report)
Time Frame: end of trial + 3wk Follow Up
|
end of trial + 3wk Follow Up
|
|
Attentional Bias (dot-probe test)
Time Frame: End of trial + 3wk Follow-up
|
End of trial + 3wk Follow-up
|
|
Emotional Stroop Interference
Time Frame: End of trial + 3wk Follow Up
|
End of trial + 3wk Follow Up
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Collaborators
Investigators
- Study Director: Willem van der Does, professor, Leiden University
- Principal Investigator: Maartje Schoorl, MS, PsyQ Nederland bv
Publications and helpful links
The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
September 1, 2008
Primary Completion (Actual)
April 1, 2010
Study Completion (Actual)
April 1, 2010
Study Registration Dates
First Submitted
September 29, 2008
First Submitted That Met QC Criteria
September 29, 2008
First Posted (Estimate)
October 1, 2008
Study Record Updates
Last Update Posted (Estimate)
July 8, 2011
Last Update Submitted That Met QC Criteria
July 7, 2011
Last Verified
July 1, 2011
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- 60-60105-98-128
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.